Navigation Links
Molecular Imaging of Colorado Joins Integrated Diagnostic Centers’ Denver Radiology Network
Date:5/16/2016

Molecular Imaging of Colorado (MIC), the wholly-owned subsidiary of statistically measured brain diagnostics company CereScan, is proud to announce it has joined Integrated Diagnostic Centers’ (IDC) metro Denver radiology network. The IDC relationship enables MIC to accept Physician Health Partners (PHP) patients and supports PHP’s commitment to providing superior cost-effective healthcare options.

“The opportunity will allow Physician Health Partners to continue its mission of coordinating high-quality, value-based care,” said John Allen, CEO of Integrated Diagnostic Centers. “MIC and PHP’s commitment to offering better diagnostic imaging solutions and care with substantial savings for patients will ensure a successful partnership for years to come.”

PHP collaborates with more than 300 primary care providers, both physicians and mid-level providers, and hundreds of specialists in the Denver metro area. The organization supports physicians by providing innovative tools and programs to help drive quality outcomes and more cost-effective healthcare to patients.

*****

“We look forward to exceeding the service expectations and values set forth by Physician Health Partners,” said Sean Strauss, Vice President of Clinical Services for Molecular Imaging of Colorado and CereScan. “We believe our superior service and cost-effective nuclear medicine solutions will produce outstanding results for PHP providers and their patients.”

With its exceptional customer service, fast turnaround and modern facility, MIC is one of the premier nuclear medicine facilities in Denver. Additionally, PHP patients will pay roughly 30 to 60 percent less for PET/CT scans at MIC when compared to other imaging centers in the region.

Molecular Imaging of Colorado is based in Littleton, Colorado, and is a wholly-owned subsidiary of CereScan. MIC provides PET/CT imaging services to the patients of Oncologists, Pulmonologists, and Urologists and any others who may need diagnostic imaging. To schedule an appointment or for more information, please call 303-954-4957 or visit http://www.MICimaging.net.

*****

CereScan is the nation’s leader in providing statistically measured brain diagnostics based on a new generation of imaging software, PET/CT (Positron Emission Tomography/Computed Tomography) and SPECT (Single Photon Emission Computed Tomography) neuroimaging technologies. Referring and treating medical experts can rely on CereScan to offer differentiated diagnoses on a wide array of brain-based disorders including:

  •     ADD/ADHD
  •     Alzheimer’s Disease
  •     Anxiety Disorder
  •     Bipolar Disorder
  •     Dementia
  •     Mild Cognitive Impairment
  •     Obsessive Compulsive Disorder
  •     Parkinson’s Disease
  •     PTSD
  •     Stroke
  •     Traumatic Brain Injury
  •     Toxic Brain Injury

About Integrated Diagnostic Centers
Headquartered in Houston, Texas, Integrated Diagnostic Centers (IDC) is a venture capital-backed private company, with a history of physician practice and ancillary service management. In 1999, it transformed its business into IDC, entering the diagnostic imaging arena. In 2007, IDC expanded its diagnostic imaging operations to a national presence through its acquisition of a national network of diagnostic imaging providers, The National Radiology Network (TNRN). Today the IDC/TNRN network includes nearly 2,000 diagnostic imaging facilities nationwide.

About Physician Health Partners
Physician Health Partners (PHP) is an integrated team of physicians and healthcare professionals committed to supporting effective patient care throughout the healthcare continuum. Founded in 1996 as a management services organization, the company believes physicians and other providers have the capability and responsibility to drive high quality, cost-effective healthcare for patients. PHP provides support to primary care physicians in improving clinical outcomes for the benefit of the patient. By improving clinical outcomes, enhancing provider performance and developing practice efficiencies, patients' health status is improved and overall healthcare costs are reduced.

About CereScan
CereScan combines state-of-the-art SPECT and PET/CT brain imaging technologies with a patient centered model of care to provide the highest level of neurodiagnostics anywhere. Using quantitative functional brain imaging, advanced imaging software, and an extensive library of clinical data, the CereScan medical team provides physicians with unmatched objective diagnostic information. CereScan helps patients and their physicians better understand the neurological basis of their conditions. In a variety of legal settings, CereScan provides objective evidence to attorneys and their clients regarding traumatic and toxic brain injuries. For researchers, CereScan provides independent pre- and post-treatment measures of organic changes in the brain along with measures of symptoms related to the brain disorder of interest. For more information, please call (866) 722-4806 or visit http://www.CereScan.com.

Read the full story at http://www.prweb.com/releases/2016/05/prweb13415055.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. European Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products Projected to Reach US$ 22.3 Mn in 2023: TMR
2. Caris Life Sciences to Present Molecular Insights Informing Treatment Strategies at the 2016 Society of Gynecologic Oncology Annual Meeting
3. Biocept to Present at Molecular Medicine Tri-Con 2016
4. Atomic Force Microscope Leader Park Systems Presents SupramolecularChemistry Webinar as Part of a Nanotechnology Series
5. Europe Molecular Diagnostics Market to Reach US$4.2 bn by 2023, Adoption of Next Generation Sequencing Technologies Rapidly Rise: Transparency Market Research
6. BioGenex Completes Construction of a State-of-the-Art Center for Cancer Diagnostics and Molecular Pathology Innovation in Hyderabad, India
7. ZeptoMetrix™ (ZMC) to Release NATtrol™ Inactivated Zika Virus for the Development of Molecular Diagnostic Assays and Ongoing Clinical Laboratory Quality Control
8. Report: Molecular Tissue and Cell-Based Testing a 2.5 Billion-Dollar Market
9. CereScan and Molecular Imaging of Colorado Add TRICARE to Approved Insurers
10. Caris Life Sciences Research Yields New Molecular Insights into Rare Breast Cancers
11. Global Molecular Diagnostics Market 2016: Latest Instrumentation and Strategic Profiles of Leading Suppliers - Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Tecan & Trinity Biotech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... -- Kineta, Inc., a biotechnology company focused on ... today announced the discovery and characterization of several ... interferon response factor 3 (IRF3) via RIG-I like ... in a murine colon carcinoma mouse model.  Furthermore, ... regression to initial drug treatment were resistant to ...
(Date:3/23/2017)... 23, 2017  Agriculture technology company Cool Planet has ... note conversion to commercialize its Cool Terra and Cool ... developing products that are simultaneously profitable as well as ... last 18 months. This latest round of funding was ... The company,s primary product, Cool Terra, ...
(Date:3/22/2017)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a ... Biobank and GSK to generate genetic sequence data from the ... will enable researchers to gain valuable insights to support advances ... of serious and life threatening diseases. ... Genetic evidence has revolutionized ...
(Date:3/22/2017)... March 22, 2017  UBM and the Massachusetts ... their extended partnership and the third annual Massachusetts Medtech ... the 21 st Annual MassMEDIC Conference held ... May 3-4, 2017. MassMEDIC will ... (ADVAMED) President and CEO, Scott Whitaker , ...
Breaking Biology Technology:
(Date:3/23/2017)... -- Research and Markets has announced the addition of ... Industry Forecast to 2025" report to their offering. ... The Global Vehicle Anti-Theft ... 8.8% over the next decade to reach approximately $14.21 billion by ... and forecasts for all the given segments on global as well ...
(Date:3/20/2017)... , March 20, 2017 At this year,s CeBIT ... -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together ... is this year,s CeBIT partner country. At the largest German biometrics company ... use: fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/9/2017)... Australia , March 9, 2017 ... the prestigious World Lung Imaging Workshop at the University ... , was invited to deliver the latest data to ... globally recognised event brings together leaders at the forefront ... developments in lung imaging. "The quality ...
Breaking Biology News(10 mins):